Back to 
BlackRock, Inc.
BlackRock, Inc.
HEPA2 quarters
Position history for BlackRock, Inc.'s holdings in Hepion Pharmaceuticals, Inc.
BlackRock, Inc. previously held 0 shares of HEPA (Hepion Pharmaceuticals, Inc.), worth $0 as of 2025-Q2.
Final Value
$0
Final Shares
0
Total Value Change
-$713
Total Shares Change
-1,658
Quarter-by-Quarter History
Other major holders of HEPA: HRT FINANCIAL LP, CITADEL ADVISORS LLC, XTX Topco Ltd, PNC FINANCIAL SERVICES GROUP, INC., FMR LLC